Evidence map›Paper›PMID 33456188›Full record

ArticleProceedings (Baylor University. Medical Center)2020

Turner syndrome and autosomal dominant polycystic kidney disease.

Rachel Styer, Matthew Stephen, Faris Hashim, Krista Birkemeier

Abstract readCase Reports
In one paragraph

Article in Proceedings (Baylor University. Medical Center), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rachel StyerDepartment of Pediatrics, Texas A&M Health Science Center, Baylor Scott & White McLane Children Medical Center, Temple, Texas.
Matthew StephenDivision of Pediatric Endocrinology, Texas A&M Health Science Center, Baylor Scott & White McLane Children Medical Center, Temple, Texas.
Faris HashimDivision of Pediatric Nephrology, Texas A&M Health Science Center, Baylor Scott & White McLane Children Medical Center, Temple, Texas.
Krista BirkemeierDivision of Pediatric Radiology, Texas A&M Health Science Center, Baylor Scott & White McLane Children Medical Center, Temple, Texas.ORCID https://orcid.org/0000-0003-2505-813X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Turner syndrome is a chromosomal disorder that involves multiple organ systems and is typically associated with short stature. A multidisciplinary approach with regular screening and surveillance is key to managing this condition's multiple comorbidities. We present a case of a young girl with Turner syndrome and associated short stature on growth hormone treatment who presented with cystic renal disease found to be autosomal dominant kidney disease. We propose reevaluation of renal screening guidelines in this population due to the potential association of growth hormone and cyst proliferation.

Indexed as

Growth hormonePKD1 mutationpolycystic kidney diseaseTurner syndrome

Identifiers

PMID33456188
PMCPMC7785201

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.